Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-01 Sale |
2021-07-02 4:16 pm |
Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director |
6,750 | $10.36 | $69,930 | 48,805 (Direct) |
View |
| 2021-06-02 Sale |
2021-06-04 4:15 pm |
Sigilon Therapeutics Inc. | SGTX | ANDERSON DANIEL GRIFFITH Director |
200,000 | $10 | $2,000,000 | 2,022,222 (Direct) |
View |
| 2020-12-08 Purchase |
2020-12-10 5:00 pm |
Sigilon Therapeutics Inc. | SGTX | ELI LILLY & Co 10% Owner |
300,000 | $18 | $5,400,000 | 2,744,443 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-18 Option Award |
2022-02-22 5:00 pm |
N/A 2032-02-17 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
230,000 | $1.48 | 230,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:00 pm |
N/A 2032-02-17 |
Sigilon Therapeutics Inc. | SGTX | Orfali May CHIEF MEDICAL OFFICER |
10,000 | $1.48 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 4:16 pm |
N/A 2032-01-02 |
Sigilon Therapeutics Inc. | SGTX | Pontes Josias VP, HEAD OF FINANCE |
65,000 | $3.03 | 65,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 4:15 pm |
N/A 2032-01-02 |
Sigilon Therapeutics Inc. | SGTX | Orfali May CHIEF MEDICAL OFFICER |
10,000 | $3.03 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 4:15 pm |
N/A 2032-01-02 |
Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER |
90,000 | $3.03 | 90,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 4:15 pm |
N/A 2032-01-02 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
400,000 | $3.03 | 400,000 (Direct) |
View |
| 2021-12-01 Option Award |
2021-12-01 4:45 pm |
N/A 2031-11-30 |
Sigilon Therapeutics Inc. | SGTX | Orfali May CHIEF MEDICAL OFFICER |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-05 4:15 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
50,000 | $0 | 73,461 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:15 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Pontes Josias VP, HEAD OF FINANCE |
11,500 | $0 | 13,339 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 4:16 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director |
6,750 | $0.57 | 48,805 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 4:16 pm |
N/A 2026-07-13 |
Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director |
6,750 | $0 | 48,805 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 4:10 pm |
N/A 2031-06-13 |
Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER |
90,000 | $0 | 90,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 07:15 am |
N/A 2031-06-23 |
Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director |
8,888 | $9.97 | 8,888 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 07:15 am |
N/A 2031-06-23 |
Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director |
8,888 | $9.97 | 8,888 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 07:15 am |
N/A 2031-06-23 |
Sigilon Therapeutics Inc. | SGTX | Patel Kavita Director |
8,888 | $9.97 | 8,888 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 07:15 am |
N/A 2031-06-23 |
Sigilon Therapeutics Inc. | SGTX | Cox John Director |
8,888 | $9.97 | 8,888 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 07:15 am |
N/A 2031-06-23 |
Sigilon Therapeutics Inc. | SGTX | Shaff Eric D. Director |
8,888 | $9.97 | 8,888 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 07:15 am |
N/A 2031-06-23 |
Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director |
8,888 | $9.97 | 8,888 (Direct) |
View |
Ownership |
2021-06-21 4:20 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Pontes Josias VP, Head of Finance |
0 | $0 | 93,154 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 4:10 pm |
N/A 2031-06-13 |
Sigilon Therapeutics Inc. | SGTX | Story Brooke Director |
17,777 | $0 | 17,777 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 08:00 am |
N/A 2031-02-10 |
Sigilon Therapeutics Inc. | SGTX | Reicin Glenn CHIEF FINANCIAL OFFICER |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 08:00 am |
N/A 2031-02-10 |
Sigilon Therapeutics Inc. | SGTX | CORZO DEYA CHIEF MEDICAL OFFICER |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 08:00 am |
N/A 2031-02-10 |
Sigilon Therapeutics Inc. | SGTX | SMITH DEVYN CHIEF OPERATING OFFICER |
95,000 | $0 | 95,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 08:00 am |
N/A 2031-02-10 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2020-12-08 Conversion |
2020-12-10 6:19 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
19,259,257 | $0 | 1,481,481 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-10 6:15 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Cox John Director |
4,444 | $0 | 4,444 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-10 6:13 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio President and CEO |
22,222 | $0 | 22,222 (Direct) |
View |
| 2020-12-08 Conversion |
2020-12-10 5:00 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | ELI LILLY & Co 10% Owner |
4,888,886 | $0 | 2,744,443 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 5:49 pm |
N/A 2030-12-02 |
Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 5:48 pm |
N/A 2030-12-02 |
Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director |
8,888 | $0 | 8,888 (Direct) |
View |
Ownership |
2020-12-03 9:00 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | ELI LILLY & Co 10% Owner |
0 | $0 | 2,444,443 (Direct) |
View |
Ownership |
2020-12-03 8:42 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | ANDERSON DANIEL GRIFFITH Director |
0 | $0 | 2,222,222 (Direct) |
View |
Ownership |
2020-12-03 8:42 pm |
N/A 2030-06-11 |
Sigilon Therapeutics Inc. | SGTX | Patel Kavita Director |
0 | $0 | 55,555 (Direct) |
View |
Ownership |
2020-12-03 8:42 pm |
N/A 2026-07-13 |
Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director |
0 | $0 | 55,555 (Direct) |
View |
Ownership |
2020-12-03 8:42 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio President and CEO |
0 | $0 | 1,112,221 (Direct) |
View |
Ownership |
2020-12-03 8:42 pm |
N/A 2029-06-05 |
Sigilon Therapeutics Inc. | SGTX | Reicin Glenn Chief Financial Officer |
0 | $0 | 223,333 (Direct) |
View |